市場調査レポート
商品コード
1291481

医薬品ファインケミカル市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Pharmaceutical Fine Chemicals Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
医薬品ファインケミカル市場:世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要:

世界の医薬品ファインケミカル市場規模は、2022年に1,326億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に6.42%の成長率(CAGR)を示し、2028年までに1,953億米ドルに達すると予測しています。

ファインケミカルとは、高値で限定的に製造される純度の高い複雑な化学物質のことです。これらの化学物質は、多段階のバッチバイオテクノロジーの手法に支えられた多目的プラントで生産されます。特殊化学品とは異なり、これらの物質は、明確な機能特性と特定の分子特性に基づいて精密に蓄積されます。回収されたファインケミカルは、ステアリン酸マグネシウムやゼラチンなどの医薬化学品を製造する際の主剤、安定剤、溶媒として使用されます。現在、これらのファインケミカルは、独自のものと非独占的なものがあり、商業的に利用可能です。

医薬品ファインケミカルの市場動向:

不整脈、脳卒中、がん、冠動脈疾患など、さまざまな神経系疾患や循環器系疾患の有病率が、特に高齢者の間で高まっていることが、医薬品ファインケミカル市場を成長へと導く主要因のひとつとなっています。これに伴い、コロナウイルス感染症(COVID-19)やその他の疾患に対抗するための新しいワクチン、医薬品、医薬品を導入するためにいくつかの国の政府機関によって行われた有利なイニシアチブは、ヘルスケア分野におけるこれらの医薬品の普及をさらに促進するものです。このことが、市場のもう一つの成長促進要因となっています。さらに、医薬品を製造するための原料として医薬品ファインケミカルを利用するためのさまざまなガイドラインが施行され、品質基準を満たすことが、市場の成長に寄与しています。その他の要因としては、製薬業界の大幅な拡大、研究開発活動への投資の増加、多くの疾患と利用可能な治療法に関する消費者の意識の高まりなどがあり、世界的に市場の明るい見通しを生み出しています。

本レポートで回答した主な質問

  • 世界の医薬品ファインケミカル市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • COVID-19は世界の医薬品ファインケミカル市場にどのような影響を与えているか?
  • 主要な地域市場とは?
  • タイプに基づく市場の内訳は?
  • 製品に基づく市場の内訳は?
  • サイズに基づく市場の内訳は?
  • アプリケーションに基づく市場の内訳は?
  • 業界のバリューチェーンにおける様々なステージは何か?
  • 業界における主要な促進要因と課題は何か?
  • 医薬品ファインケミカルの世界市場の構造と主要企業は?
  • 業界における競合の程度はどの程度か?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 医薬品ファインケミカルの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 タイプ別市場内訳

  • プロプライエタリ
    • 市場動向
    • 市場予測
  • ノンプロプライエタリ
    • 市場動向
    • 市場予測

第7章 製品別市場内訳

  • 有効成分
    • 市場動向
    • 市場予測
  • 基本的な構成要素
    • 市場動向
    • 市場予測
  • 先端中間体
    • 市場動向
    • 市場予測

第8章 規模別市場内訳

  • 大型分子
    • 市場動向
    • 市場予測
  • 低分子化合物
    • 市場動向
    • 市場予測

第9章 アプリケーション別市場内訳

  • 循環器
    • 市場動向
    • 市場予測
  • 神経系
    • 市場動向
    • 市場予測
  • 腫瘍学的
    • 市場動向
    • 市場予測
  • 呼吸器
    • 市場動向
    • 市場予測
  • 消化器系
    • 市場動向
    • 市場予測
  • 筋骨格系
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BASF SE
    • Borregaard ASA
    • CHEMADA Industries Ltd.(Turpaz)
    • Denisco Chemicals Pvt Ltd
    • Dupont De Nemours Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Koninklijke DSM N.V.
    • Lonza Group AG
    • Solvay S.A.
    • Syntor Fine Chemicals Ltd.(Aceto Corporation)
    • W. R. Grace and Co.(Standard Industries Inc.)
図表

List of Figures

  • Figure 1: Global: Pharmaceutical Fine Chemicals Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Fine Chemicals Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pharmaceutical Fine Chemicals Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Pharmaceutical Fine Chemicals Market: Breakup by Product (in %), 2022
  • Figure 6: Global: Pharmaceutical Fine Chemicals Market: Breakup by Size (in %), 2022
  • Figure 7: Global: Pharmaceutical Fine Chemicals Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Pharmaceutical Fine Chemicals Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Pharmaceutical Fine Chemicals (Proprietary) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Pharmaceutical Fine Chemicals (Proprietary) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Pharmaceutical Fine Chemicals (Neurological) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Pharmaceutical Fine Chemicals (Neurological) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Pharmaceutical Fine Chemicals (Oncological) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Pharmaceutical Fine Chemicals (Oncological) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Pharmaceutical Fine Chemicals (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Pharmaceutical Fine Chemicals (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Pharmaceutical Fine Chemicals (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Pharmaceutical Fine Chemicals (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia-Pacific: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia-Pacific: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Breakup by Country (in %), 2022
  • Figure 85: Middle East and Africa: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Pharmaceutical Fine Chemicals Industry: SWOT Analysis
  • Figure 87: Global: Pharmaceutical Fine Chemicals Industry: Value Chain Analysis
  • Figure 88: Global: Pharmaceutical Fine Chemicals Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Fine Chemicals Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Size (in Million US$), 2023-2028
  • Table 5: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Pharmaceutical Fine Chemicals Market: Competitive Structure
  • Table 8: Global: Pharmaceutical Fine Chemicals Market: Key Players
目次
Product Code: SR112023A5910

Market Overview:

The global pharmaceutical fine chemicals market size reached US$ 132.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 195.3 Billion by 2028, exhibiting a growth rate (CAGR) of 6.42% during 2023-2028.

Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.

Pharmaceutical Fine Chemicals Market Trends:

The increasing prevalence of various neurological and cardiovascular diseases, including arrhythmias, stroke, cancer, and coronary artery ailments, especially amongst the geriatric population, is one of the prime factors driving the pharmaceutical fine chemical market toward growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel vaccines, drugs, and pharmaceutical medications for retaliating against coronavirus diseases (COVID-19) and several other disorders is further facilitating the widespread adoption of these medications in the healthcare sector. This, in turn, is acting as another growth-inducing factor in the market. Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical fine chemicals market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, product, size and application.

Breakup by Type:

  • Proprietary
  • Non-proprietary

Breakup by Product:

  • Active Ingredients
  • Basic Building Blocks
  • Advanced Intermediates

Breakup by Size:

  • Big Molecules
  • Small Molecules

Breakup by Application:

  • Cardiovascular
  • Neurological
  • Oncological
  • Respiratory
  • Gastrointestinal
  • Musculoskeletal
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.).

Key Questions Answered in This Report:

  • How has the global pharmaceutical fine chemicals market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical fine chemicals market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the size?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical fine chemicals market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Pharmaceutical Fine Chemicals Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Type

  • 6.1  Proprietary
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Non-proprietary
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7   Market Breakup by Product

  • 7.1  Active Ingredients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Basic Building Blocks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Advanced Intermediates
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Size

  • 8.1  Big Molecules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Small Molecules
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by Application

  • 9.1  Cardiovascular
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Neurological
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Oncological
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Respiratory
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5  Gastrointestinal
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6  Musculoskeletal
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7  Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  BASF SE
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2  Borregaard ASA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3  CHEMADA Industries Ltd. (Turpaz)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4  Denisco Chemicals Pvt Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5  Dupont De Nemours Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  Eastman Chemical Company
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Evonik Industries AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9  Lonza Group AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  Solvay S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11  Syntor Fine Chemicals Ltd. (Aceto Corporation)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12  W. R. Grace and Co. (Standard Industries Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis